INDP - Indaptus Therapeutics, Inc.
0.825
0.015 1.818%
Share volume: 14,481
Last Updated: 03-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
0.03%
PREVIOUS CLOSE
CHG
CHG%
$0.81
0.01
0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 05-08-2024 | 08-12-2024 | 11-12-2024 | |
| Assets | ||||
| Total Assets | 10.949 M | 8.122 M | 8.240 M | |
| Current Assets | 10.293 M | 7.488 M | 7.629 M | |
| Inventories | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | |
| Current Cash | 9.742 M | 7.302 M | 7.381 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 0.000 | 0.000 | 0.000 | |
| Other Assets | 655.846 K | 633.358 K | 610.383 K | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||
| Total Liabilities and shareholders’ equity | 10.949 M | 8.122 M | 8.240 M | |
| Total liabilities | 1.588 M | 1.956 M | 2.236 M | |
| Total current liabilities | 1.537 M | 1.928 M | 2.232 M | |
| Accounts Payable | 1.435 M | 1.825 M | 2.128 M | |
| Other liabilities | 50.664 K | 27.579 K | 4.007 K | |
| Current long term debt | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 50.664 K | 27.579 K | 4.007 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 9.361 M | 6.166 M | 6.003 M | |
| Common stock | 58.584 M | 59.405 M | 62.311 M | |
| Retained earnings | -49.224 M | -53.239 M | -56.308 M |